First batch of Pfizer's Paxlovid pill for Covid-19 treatment arrives in Singapore


Paxlovid was granted interim authorisation by the HSA on Feb 3 under the Pandemic Special Access Route. - The Straits Times/ANN

SINGAPORE, Feb 13 (The Straits Times/ANN): The first batch of Pfizer's antiviral oral pill, Paxlovid, arrived in Singapore this week, said Health Minister Ong Ye Kung on Saturday (Feb 12).

The drug is the first oral anti-viral medicine that has been approved by the Health Sciences Authority (HSA) for the treatment of Covid-19 infections here.

Get 20% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Singapore , Arrival , Covid-19 , Pills , Pfizer

Next In Aseanplus News

Pakistan begins registration of kite makers ahead of Basant 2027
Cambodia’s army to resume joint military exercises with the US next year
Laos, Singapore sign carbon credits agreement
Almost a million Myanmar pearls produced in April-August period
Japanese film brings Vietnam veteran's anti-war warning to new generation
Philippines expands access to free tertiary education
Eleven SMART personnel depart for Nepal with over 12 tonnes of gear
Indonesia steps up fight against wildfire that sparked hazardous haze
Air in central Singapore remains unhealthy, PSI in western and eastern regions dip to moderate
Lane widening on Besraya completed, opens to traffic on Monday

Others Also Read